Weight loss drugs such as Ozempic, Wegovy and Zepbound may be linked to a higher risk of male pattern hair loss, with men already genetically predisposed to the condition facing a 7 per cent added risk, according to a new study led by researchers at NYU Langone Health. Published online on September 3 in the.
